<< Предыдущая

стр. 4
(из 4 стр.)

ОГЛАВЛЕНИЕ



Руководство по оказанию помощи ВИЧ-инфицированным детям. Под ред. С. Зайхнера и Дж. Рид
9-9
Стандартное ведение ребенка



HIV-infected infants. J. Infect. Dis. 178 (1998), 101–8.
at risk of HIV-1 infection monitored prospectively from birth.
Pediatrics 96 (1995), 451–8.
29. Shearer W. T., Quinn T. C., LaRussa P. et al. Viral load and
20. Moye J., Rich K. C., Kalish L. A. et al. Natural history of disease progression in infants infected with human
somatic growth in infants born to women infected by human immunodeficiency virus type 1. New Engl. J. Med. 336 (1997),
immunodeficiency virus. J. Pediatr. 128 (1996), 58–69. 1337–42.
21. DeMartino M., Tovo P. A., Galli L. et al. Puberty in perinatal 30. Palumbo P. E., Raskino C., Fiscus S. et al. Predictive value of
HIV-1 infection: a multicenter longitudinal study of 212 quantitative plasma HIV RNA and CD4+ lymphocyte count in
children. AIDS 15 : 12 (2001), 1527–34. HIV-infected infants and children. J. Am. Med. Assoc. 279 : 10
(1998), 756–61.
22. Arpadi S. M., Cuff P. A., Horlick M., Wang J. & Kotler D. P.
Lipodystrophy in HIV-infected children is associated with high 31. Dunn D. HIV Paediatric Prognostic Markers Collaborative
viral load and low CD4+ -lymphocyte count and CD4+ - Study Group. Short-term risk of disease progression in HIV-1-
lymphocyte percentage at baseline and use of protease inhibitors infected children receiving no antiretroviral therapy or
and stavudine. J. AIDS 27 : 1 (2001), 30–4. zidovudine monotherapy: a meta-analysis. Lancet 362 : 9396
(2003): 1605–11.
23. Melvin A. J., Lennon S., Mohan K.M. & Purnell J.Q. Metabolic
abnormalities in HIV type 1-infected children treated and not
32. Centers for Disease Control and Prevention 1999 revised
treated with protease inhibitors. AIDS Res. Hum. Retroviruses 17
guidelines for prophylaxis against Pneumocystis carinii
: 12 (2001), 1117–23. pneumonia for children infected with or perinatally exposed to
24. Centers for Disease Control and Prevention. Recommended human immunodeficiency virus. MMWR 48 : RR-10 (1999).
Childhood and Adolescent Immunization Schedule-United
33. Centers for Disease Control and Prevention 1999 revised
States, 2004. MMWR, 53 (2004), Q1–3.
guidelines for prophylaxis against Mycobacterium avium
25. Diamond G. W. Developmental problems in children with HIV intracellulare in patients infected with human immunodeficiency
infection. Ment. Retard. 27 : 4 (1989), 213–7. virus. MMWR 48 : RR-10 (1999).
26. Brown L. K., Lourie K. J. & Pao M. Children and adolescents 34. Havens J. F., Mellins C. A. & Hunter J. Psychiatric aspects of
living with HIV and AIDS: a review. J. Child. Psychol. HIV/AIDS in childhood and adolescence. In M. Rutter & E.
Psychiatry 41 : 1 (2000), 81–96. Taylor (eds.), Child and Adolescent Psychiatry: Modern
27. Mofenson L. M., Korelitz J., Meyer W. A. et al. The relationship Approaches. Fourth Edition. Oxford, England: Blackwell
(2001), pp. 828–41.
between serum human immunodeficiency virus type 1 (HIV-1)
RNA level, CD4 lymphocyte percent, and long-term mortality
35. Mellins C. A., Brackis-Cott E., Dolezal C., Richards A.,
risk in HIV-1 infected children. National Institute of Child Nicholas S. & Abrams E. J. Patterns of HIV status disclosure to
Health and Human Development Intravenous Immunoglobulin
perinatally infected HIV-positive children and subsequent
Clinical Trial Study Group. J. Infect. Dis. 175 (1997), 1029–38.
mental health outcomes. Clin. Child Psychol. Psychia 7 (2001),
101–14.
28. Abrams E. J., Weedon J., Steketee R. W. et al. Association of
HIV viral load early in life with disease progression among




Руководство по оказанию помощи ВИЧ-инфицированным детям. Под ред. С. Зайхнера и Дж. Рид

<< Предыдущая

стр. 4
(из 4 стр.)

ОГЛАВЛЕНИЕ